News 2024-03-08
Join Our Founder and CEO @ DCAT Week
Join Our Founder and CEO @ DCAT Week
What:
DCAT Member Company Announcement Forum
When:
10:36-10:43AM, on Monday March 18, 2024
Where:
InterContinental Barclay, Grand Ballroom (2nd Floor)
Porton Pharma Solutions Ltd (hereinafter referred to as Porton or the Company) will participate in the DCAT Week which will be held in New York, from March 18-21, 2024.
As the premiere event in New York City for the Global Bio/Pharmaceutical Manufacturing Value Chain, DCAT Week garners annual industry attention. Porton has consistently participated in this esteemed gathering. At this year’s conference, our Chairman & CEO, Oliver Ju, is scheduled to speak at the DCAT Member Company Announcement Forum on the opening day. He will unveil our latest European and US facilities and capabilities, highlighting how these expansions streamline and enhance our ability to meet your unique development needs with greater ease.
Throughout DCAT Week, the Porton management team, our business development (BD) specialists, and our scientists are eager to connect with you in New York.
Schedule a meeting with us: Arsalan Khan
Others
More
News 2025-04-16
Porton Advanced's End-to-End CDMO Solutions Accelerates IND Approval of Tasly's Innovative Dual-Targeting CAR-T Therapy
April 12, 2025 - Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD’s Innovative Dual-Targeting CAR-T Therapy, "P134 Cell Injection," which has received Investigational New Drug (IND) approval from China's National Medical Products Administration (NMPA) (Approval No.: 2025LP01030). This breakthrough CAR-T therapy is indicated for recurrent glioblastoma (GBM).

News 2025-04-11
Porton Newsletter - Q1 2025 Recap
Technical Enabling Services & Solutions Company Events ESG Marketing Activities